Richter Transformation clinical trials at UCSF

1 research study open to eligible people

Richter transformation is when CLL changes into a more dangerous lymphoma. UCSF is studying first-in-human therapies to assess safety and anti-cancer activity. UCSF is also running trials of immune and targeted drugs for these patients.

Showing trials for

  • NX-1607 in Adults With Advanced Malignancies

    open to eligible people ages 18 years and up

    This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

    San Francisco, California and other locations

Our lead scientists for Richter Transformation research studies include .

Last updated: